Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies.

Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.
Editor´s Picks
Can Tax Breaks Boost Private Health Insurance in China?(8/15/2017 )  (Premium)
New Research Compares Drug Regulators Around the Globe(8/15/2017 )  (Premium)
Beijing Courts Issued Consequential Judgments On Life-Science Patents(8/15/2017 )  (Premium)
The Market
Chinese Human Vaccine Market To Rise Quickly Before 2021(8/14/2017 )  (Premium)
Industry News
CFDA Approves BMS's Baraclude as First Pediatric HBV Drug in China(8/18/2017 )  (Premium)
Ascletis In-licenses Medivir's Novel HCV Drug Candidate(8/18/2017 )  (Premium)
50 Domestically-listed Chinese Pharma Companies Report H1 Performance(8/18/2017 )  (Premium)
WuXi Biologics and Gloria Pharma Outlicense PD-1 Antibody to Arcus Biosciences(8/17/2017 )  (Premium)
GSK, AliHealth Join Hands to Build Vaccine Promotion Channel with Initial Focus on Cervarix(8/17/2017 )  (Premium)
Prometic Seals Joint Venture and Licensing Deal with Chinese Partner(8/16/2017 )  (Premium)
Zai Lab Files for NASDAQ IPO(8/16/2017 )  (Premium)
Antengene Raises $21M in Series A Financing Led by Qiming Ventures(8/15/2017 )  (free)
HitGen, Aduro Form New Drug Discovery Partnership(8/15/2017 )  (Premium)
Regulatory News
CFDI to Initiate Clinical Data Inspection of 32 Drug Products (#13)(8/18/2017 )  (Premium)
CFDA Issues Announcement to Clarify Over Published Reference Drugs for BE Studies(8/18/2017 )  (Premium)
NDRC Solicits Comments on Pricing Guideline for Shortage Drug and API Businesses(8/15/2017 )  (Premium)
CFDA Issues National Drug Abuse Monitoring Annual Report (2016)(8/14/2017 )  (Premium)
General Health
Smoking-unrelated Lung Cancer Jumps in China(8/16/2017 )  (Premium)
Legal/IPR News
China Sets Up New IP Rights Center for Manufacturing and Biopharma Industries(8/17/2017 )  (free)
China Issues Interpretations for Application of Criminal Laws for Faking Drug and Medical Device Registration Data(8/15/2017 )  (Premium)
USTR Promises Thorough Investigation of China's IP Practices(8/14/2017 )  (Premium)
People in the News
Recent Executive Moves(8/17/2017 )  (Premium)
© Wicon International GroupˇˇSupport by: www.heightow.com Home | Site map | Contact Us | Links